- Business
- Glanbia plc operates as a global nutrition company focused on developing and marketing nutritional products and ingredients for consumer and industrial applications. Headquartered in Kilkenny, Ireland, and founded in 1997 through the merger of Avonmore Foods plc and Waterford Foods plc, the company conducts operations across North America, Europe, Asia-Pacific, Latin America, and other regions, with North America serving as its largest market. Glanbia plc structures its business into three primary segments: Glanbia Nutritionals, which manufactures and sells cheese, dairy and non-dairy nutritional and functional ingredients, vitamin and mineral premixes, and flavor solutions; Glanbia Performance Nutrition, which offers sports and lifestyle nutrition products including powders, ready-to-eat bars and snacks, ready-to-drink beverages under brands such as Optimum Nutrition, Isopure, BSN, think!, and Nutramino; and Joint Ventures, encompassing cheese production partnerships like those with Leprino Foods.
The company targets health and fitness enthusiasts, athletes, food and beverage manufacturers, pharmaceutical firms, and health-conscious consumers through channels including specialty retail, online platforms, gyms, food-drug-mass-club outlets, and business-to-business sales. Glanbia plc maintains a workforce of approximately 5,700 employees and distributes its consumer brands and ingredients in over 130 countries. Tirlán Co-operative Society Limited, formerly Glanbia Co-operative Society, holds the largest shareholder position stemming from the company's cooperative origins.
Recent developments include the 2023 acquisition of Flavor Producers LLC, a U.S.-based flavor producer, for an initial $300 million plus up to $55 million in deferred consideration, enhancing Glanbia Nutritionals' capabilities in natural and organic flavors; the launch of new Isopure products such as an updated formula, Protein Water ready-to-drink innovation, and a "More of What Matters" creative campaign driving household penetration growth; and the sale of the SlimFast brand, incurring a $30 million charge confirmed in annual accounts. In Q3 2025, Glanbia plc reported revenue growth fueled by strategic product launches and acquisitions, alongside ongoing capacity enhancements, business integrations, and IT investments with capital expenditure projected between $80 million and $90 million. The company continues its €100 million share buyback program initiated in February 2024 and invests heavily in R&D, launching over 30 new health and wellness products in 2023 that contributed to a 10% revenue increase from innovations.